UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
November 19, 2004
Date of Report (date of earliest event reported)
BIOMERICA, INC.
---------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 0-8765 95-2645573
-------- ------ ----------
(State or Other (Commission (IRS Employee
Jurisdiction of File Number) Identification
Number)
1533 Monrovia Avenue
Newport Beach, California 92663
-------------------------------
(Address of Principal Executive Offices
Including Zip Code)
949-645-2111
------------
(Registrant's Telephone Number,
Including Area Code)
----------
(Former Name or Former Address if Changed
Since Last Report)
Table of Contents:
------------------
Item 1.01 Entry into an amendment of an agreement that is material to the
registrant.
Item 9.01 Financial Statements and Exhibits
Signatures
Exhibit 99.1
Amendment of the Note, Loan and Modification Agreement.
Item 1.01 Entry into an amendment of an agreement that is material to the
registrant.
On November 19, 2004, the Company entered into an agreement entitled
"Amendment of the Note, Loan and Modification Agreement". This amends the "Loan
Modification, Forbearance and Security Agreement" and "Amended and Restated
Promissory Note" which were included as exhibits to the Form 10QSB filed April
14, 2004. The Amendment of the Note, Loan and Modification Agreement is filed
herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
99.1 Amendment of the Note, Loan and Modification Agreement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOMERICA, INC.
Dated: November 19, 2004 By: /s/ Zackary S. Irani
-------------------------------
Name: Zackary S. Irani
Title: Chief Executive Officer